Literature DB >> 7508957

The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

R J Ross1, J Rodriguez-Arnao, J Bentham, J H Coakley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7508957     DOI： 10.1007/bf01708801

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  43 in total

1.  Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy.

Authors:  P Hossenlopp; B Segovia; C Lassarre; M Roghani; M Bredon; M Binoux
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

2.  Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity.

Authors:  L C Giudice; E M Farrell; H Pham; G Lamson; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

Review 3.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

4.  Growth hormone secretion: its regulation and the influence of nutritional factors.

Authors:  R J Ross; C R Buchanan
Journal:  Nutr Res Rev       Date:  1990-01       Impact factor: 7.800

5.  Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.

Authors:  R C Baxter; C T Cowell
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

6.  Effects of recombinant human growth hormone on donor-site healing in severely burned children.

Authors:  D N Herndon; R E Barrow; K R Kunkel; L Broemeling; R L Rutan
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

7.  Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.

Authors:  R A Gelfand; E J Barrett
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

8.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

Authors:  R Ross; J Miell; E Freeman; J Jones; D Matthews; M Preece; C Buchanan
Journal:  Clin Endocrinol (Oxf)       Date:  1991-07       Impact factor: 3.478

9.  Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery.

Authors:  H C Ward; D Halliday; A J Sim
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

10.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

Authors:  J F Caro; J Poulos; O Ittoop; W J Pories; E G Flickinger; M K Sinha
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808
View more
  3 in total

Review 1.  Stimulation of chondrogenic differentiation of mesenchymal stem cells.

Authors:  Da-Ae Yu; Jin Han; Byung-Soo Kim
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

2.  The role of anabolic hormones for wound healing in catabolic states.

Authors:  Robert H Demling
Journal:  J Burns Wounds       Date:  2005-01-17

3.  The use of anabolic agents in catabolic states.

Authors:  Robert Demling
Journal:  J Burns Wounds       Date:  2007-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.